Caliber Imaging & Diagnostics to Present at AdvaMed 2013: The MedTech Conference on September 24, 2013
ROCHESTER, N.Y. and BOSTON, Sep 19, 2013 (GLOBE NEWSWIRE via COMTEX) --
Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid, Inc., is presenting at the AdvaMed 2013: The MedTech Conference on September 24, 2013 at 9:45 AM EDT in Washington, DC.
L. Michael Hone, Chief Executive Officer of Caliber I.D., will describe the Company's platform of VivaScope confocal microscopes. The FDA-cleared VivaScope cellular imaging devices provide patients the option of a painless, noninvasive optical skin biopsy in lieu of expensive and painful traditional skin biopsy while also having potential applications in several other medical and research specialties. He will discuss the Company's strategy, markets and growth plans as they relate to cost efficiency in the scope of dermatological and medical care.
Mr. Hone said, "We look forward to presenting our proprietary, cutting-edge VivaScope imaging technology at AdvaMed 2013 and meeting with other innovators and leaders in medical technology. With our global markets spanning clinicians, academic researchers and pharmaceutical developers, we plan to educate attendees on VivaScope's capabilities not only for dermatology, but also on the feasibility of its applications in neuropathy, head and neck, and breast surgery."
About AdvaMed 2013: The MedTech Conference
AdvaMed 2013 is the leading MedTech conference in North America, bringing more than 1,000 companies together in a uniquely multifaceted environment for business development, capital formation, innovative technology showcasing, world-class educational opportunities and networking. An event rich in international flavor and featuring a deep, diverse attendee list that includes influential policy-makers, business executives and media, AdvaMed 2013 seeks to advance industry discussion from key perspectives through detailed panel sessions, executive forums and more.
About Caliber Imaging & Diagnostics
Caliber Imaging & Diagnostics' platform of products offer increased productivity from the research laboratory to the doctor's office or the surgeon's operating room. Caliber I.D.'s platform of products provide precise accuracy, consistent reliability, and online backup that all combine to lead to better patient care. For more information about Caliber I.D. and its products, please visit www.caliberid.com.
VivaScope is a registered trademark of Caliber Imaging & Diagnostics.
This press release contains "forward looking statements" within the meaning of the Securities Litigation Reform Act of 1995. These statements include but are not limited to our plans, objectives, expectations and intentions and other statements that contain words such as "expects," "contemplates," "anticipates," "plans," "intends," "believes," "assumes" and variations of such words or similar expressions that predict or indicate future events or trends, or that do not relate to historical matters. These statements are based on our current beliefs or expectations and are inherently subject to significant known and unknown uncertainties and changes in circumstances, many of which are beyond our control. There can be no assurance that our beliefs or expectations will be achieved and actual results may differ materially from our beliefs or expectations due to financial, economic, business, regulatory and other factors or conditions affecting us or our industry in general, as well as more specific risks and uncertainties facing us, such as those set forth in the Risk Factors section of the Forms 10-Q and 10-K filed by us with the Securities and Exchange Commission.
CONTACT: Richard Pulsifer
Chief Financial Officer
Dian Griesel Inc.
Dian Griesel Inc.
Susan Forman or Laura Radocaj
[ Back To Technology News's Homepage ]